"title","doi","altmetric_jid","score","X1d","X3d","X1w","X1m","authors","author_corresponding","author_corresponding_institution","date","version","type","license","category","jatsxml","abstract","published","server","upupdate_time"
"Integrative Chemical Genetics Platform Identifies Condensate Modulators Linked to Neurological Disorders","10.1101/2025.06.07.658469","biorxiv",19.45,17.2,19.45,19.45,19.45,"Poch, D.; Mukherjee, C.; Mallik, S.; Todorow, V.; Kuiper, E. F. E. J.; Dhingra, N.; Surovtseva, Y. V.; Schlieker, C.","Christian Schlieker","Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.","2025-06-08","1","new results","cc_no","cell biology","https://www.biorxiv.org/content/early/2025/06/08/2025.06.07.658469.source.xml","Aberrant biomolecular condensates are implicated in multiple incurable neurological disorders, including Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), and DYT1 dystonia. However, the role of condensates in driving disease etiology remains poorly understood. Here, we identify myeloid leukemia factor 2 (MLF2) as a disease-agnostic biomarker for phase transitions, including stress granules and nuclear condensates associated with dystonia. Exploiting fluorophore-derivatized MLF2 constructs, we developed a high-content platform and computational pipeline to screen modulators of NE condensates across chemical and genetic space. We identified RNF26 and ZNF335 as protective factors that prevent the buildup of nuclear condensates sequestering K48-linked polyubiquitinated proteins. Chemical screening identified four FDA-approved drugs that potently modulate condensates by resolving polyubiquitinated cargo and MLF2 accumulation. Our exploratory integrated chemical-genetics approach suggests that modulation of zinc, and potentially autophagy and oxidative stress, is critical for condensate modulation and nuclear proteostasis, offering potential therapeutic strategies for neurological disorders. Application of our platform to a genome-wide CRISPR KO screen identified strong enrichment of candidate genes linked to primary microcephaly and related neurodevelopmental disorders. Two hypomorphic microcephaly-associated alleles of ZNF335 failed to rescue nuclear condensate accumulation in ZNF335 KO cells, suggesting that aberrant condensates and impaired nuclear proteostasis may contribute to the pathogenesis of microcephaly.

HIGHLIGHTSO_LIMLF2 emerges as a disease-agnostic condensate biomarker co-localizing with TDP-43 and G3BP1
C_LIO_LIFDA-approved drugs target condensates linked to perturbed proteostasis.
C_LIO_LIRNF26 and ZNF335 are identified as modulators of nuclear phase transitions.
C_LIO_LIMicrocephaly patient disease alleles fail to counteract aberrant condensates.
C_LI","NA","biorxiv",1749593357929
"Embryonic development of C. elegans sense organs","10.1101/2025.06.04.657903","biorxiv",15.399999999999997,15.399999999999997,15.399999999999997,15.399999999999997,15.399999999999997,"Wexler, L.; Kolotuev, I.; Heiman, M. G.","Maxwell G Heiman","Harvard Medical School, Boston Children\'s Hospital","2025-06-08","1","new results","cc_by_nc_nd","developmental biology","https://www.biorxiv.org/content/early/2025/06/08/2025.06.04.657903.source.xml","C. elegans sense organs provide a powerful model for understanding how different cell types interact to assemble a functional organ. Each sense organ is composed of two glial cells, called the sheath and socket, and one or more neurons. A major challenge in studying their development has been the lack of methods to directly observe these structures in the embryo. Here, we mine a recently published high-resolution ultrastructural dataset of a comma-stage embryo that provides an untapped resource for visualizing early developmental events. From this dataset we reconstructed all head sense organs (two amphid (AM), four cephalic (CEP), six inner labial (IL), four outer labial quadrant (OLQ), and two outer labial lateral (OLL)). Symmetric sense organs were at different stages of morphogenesis, allowing us to infer developmental steps by which they form. First, we found that the sheath glial cell begins wrapping its partner neurons at the distal tip of the dendrites where it self-fuses into a seamless tube and then ""zippers"" down the dendrite. In many cases, sheath glia wrap the progenitors of partner neurons prior to their terminal division. After sheath wrapping has begun, the socket glia wraps the sheath glia circumferentially before presumably elongating to form the mature sheath-socket channel. We also observed transient interactions not found in the mature animal, such as amphid sheath glia wrapping the AUA neuron, that may reflect ancestral relationships. This study demonstrates the value of large public EM datasets that can be mined for new insights, and sheds light on how neurons and glia undergo coordinated morphogenesis.","NA","biorxiv",1749593357929
"Blind De Novo Design of Dual Cyclic Peptide Agonists Targeting GCGR and GLP1R","10.1101/2025.06.06.658268","biorxiv",15.549999999999999,12.049999999999999,15.549999999999999,15.549999999999999,15.549999999999999,"Li, Q.; Wiita, E.; Helleday, T.; Bryant, P.","Patrick Bryant","Stockholm University","2025-06-08","1","new results","cc_by_nc","bioinformatics","https://www.biorxiv.org/content/early/2025/06/08/2025.06.06.658268.source.xml","Agonists of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP1R) are key to treating metabolic diseases like type 2 diabetes and obesity, but often limited by being linear. Cyclic peptides offer greater stability and potential oral delivery, but their de novo design with computational methods as agonists is unproven. Here, we used the EvoBind AI platform to design cyclic peptide agonists for GCGR from sequence alone, without any structural templates or prior binding site information. EvoBind consistently identified the receptors activation surface, producing peptides that also activated GLP1R. Of three synthesised peptides, two showed potent dual activation of GCGR and GLP1R in cAMP assays, while all three activate GLP1R, with the 18-residue design achieving EC50 values of 32 nM (GLP1R) and 542 nM (GCGR), rivalling natural hormones. The designed sequences show no similarity to known agonists, and structural modelling indicates that they adopt novel binding modes compatible with active-state stabilisation. This is made possible by EvoBinds purely sequence-based, template-free approach, which enables the discovery of alternative solutions that are inaccessible to structure-guided methods. This study presents the first successful blind de novo design of a cyclic peptide agonist for a G protein-coupled receptor (GPCR), using only the receptor sequence as input. The findings highlight EvoBinds capacity to go beyond static binding, offering a generalisable strategy for therapeutic discovery through target-agnostic, sequence-driven peptide design.","NA","biorxiv",1749593357929
"Student-led experimental evolution reveals novel biofilm regulatory networks underlying adaptations to multiple niches","10.1101/2025.06.06.658356","biorxiv",61.85000000000006,10.599999999999998,58.400000000000055,61.85000000000006,61.85000000000006,"Matela, A. M.; Siatkowski, C. W.; Yan, C.; Thiagarajan, S.; Cooper, V. S.","Vaughn S Cooper","University of Pittsburgh","2025-06-06","1","new results","cc_by_nc","microbiology","https://www.biorxiv.org/content/early/2025/06/06/2025.06.06.658356.source.xml","We established a research-education partnership known as EvolvingSTEM that provides secondary school students the opportunity to conduct authentic research experiments centered on microbial evolution. These experiments are currently conducted by thousands of high school students and can offer an unprecedented window into biofilm adaptation while building a community of young researchers. Providing high school students access to research experiences improves learning and can have positive and long-lasting impacts on their attitudes towards science. Moreover, student research can make impactful scientific contributions. Through EvolvingSTEM, students evolve populations of Pseudomonas fluorescens in a biofilm bead model and observe heritable changes in colony morphology. Genome sequencing of 70 mutants that they picked identified parallel mutations in genes known to regulate biofilm growth (wsp, yfiBNR, morA, fuzY). We also uncovered novel adaptations: loss-of-function mutations in phosphodiesterase PFLU0185 that did not alter colony morphology, and mutations affecting periplasmic disulfide bond formation producing small colonies. PFLU0185 mutations consistently reached high frequencies and phenotyping revealed roles in cyclic di-GMP regulation, biofilm formation, and motility, prompting us to name this gene bmo (biofilm and motility optimizer). Competition experiments and microscopy demonstrated bmo mutants employ generalist strategies and coexist with the ancestor and specialist mutants through niche differentiation. Consequently, phenotypic diversity is maintained, with smooth (ancestral and bmo) colonies consistently outnumbering wrinkly and fuzzy variants. The study advances understanding of biofilm genetic architecture while demonstrating that student-led research can uncover mechanisms of microbial adaptation relevant to Pseudomonas infection biology and provide transformative STEM experiences.

IMPORTANCEBacterial biofilms dominate microbial life, yet their evolutionary genetics remain incompletely understood. This science education project engages thousands of high school students in experimental evolution, yielding discoveries about biofilm adaptation while transforming their science education. Selected mutants included PFLU0185/bmo, a conserved phosphodiesterase that helps bacteria balance the competing demands of attachment and dispersal essential for biofilm life cycle success. The finding that smooth-colony generalists rather than conspicuous variants dominate biofilm adaptation adds to our understanding of the process of niche differentiation in biofilms. This work also demonstrates the power of distributed research networks for discovery of new genetic pathways of adaptation. Students gained authentic research experience, potentially inspiring them to join the next generation of scientists, while identifying mutants adapted to discrete conditions that maintain diversity within biofilms. This synergy between education and discovery offers a scalable model for addressing complex biological questions while developing scientific literacy in diverse classrooms.","NA","biorxiv",1749593357929
"Social environment affects vocal individuality in a non-learning species","10.1101/2025.06.06.658121","biorxiv",10.799999999999999,9.799999999999999,10.799999999999999,10.799999999999999,10.799999999999999,"Madhavan, M.; Hornatova, L.; Salek, M.; Pruchova, A.; Linhart, P.","Malavika Madhavan","University of South Bohemia in Ceske Budejovice","2025-06-06","1","new results","cc_by_nc_nd","animal behavior and cognition","https://www.biorxiv.org/content/early/2025/06/06/2025.06.06.658121.source.xml","Individual recognition is fundamental to the social behaviour of many animals. In high-density populations, animals encounter and compete with conspecific rivals more frequently, which should enhance the individuality of their signals to facilitate recognition among neighbours. We investigated vocal individuality in male territorial calls of two populations of little owls (Athene noctua) with different densities. Further, to explore the potential influence of local population distribution on individuality, we also examined isolated males without neighbours and clumped males with neighbours. Our findings indicate higher individuality at higher densities across both scenarios, measured using two individuality metrics: Beechers information statistic and Discrimination score. Additionally, clumped males exhibited significantly lower acoustic niche overlaps compared to isolated males, suggesting that the immediate social environment might be more influential than larger-scale population density patterns. This study is the first to demonstrate that vocal individuality in a territorial species is influenced by conspecific density, similar to findings in group-living and colonial species.","NA","biorxiv",1749593357929
"OmnibusX: A unified platform for accessible multi-omics analysis","10.1101/2025.06.06.658217","biorxiv",13.299999999999999,9.399999999999999,13.299999999999999,13.299999999999999,13.299999999999999,"Truong, L.; Truong, T.; Nguyen, H.","Huy Nguyen","OmnibusXLab","2025-06-08","1","new results","cc_by_nc_nd","bioinformatics","https://www.biorxiv.org/content/early/2025/06/08/2025.06.06.658217.source.xml","OmnibusX is an integrated, privacy-centric platform that enables code-free multi-omics data analysis by bridging computational methodologies with user-friendly interfaces. Designed to overcome challenges posed by fragmented analytical tools and high computational barriers, OmnibusX consolidates workflows for diverse technologies - including bulk RNA-seq, single-cell RNA-seq, single-cell ATAC-seq, and spatial transcriptomics - into a single, cohesive application. The application integrates established open-source tools such as Scanpy, DESeq2, SciPy, and scikit-learn into transparent, reproducible pipelines, offering users control over analytical parameters. Additionally, OmnibusX features proprietary modules, including a highly accurate cell-type prediction engine and an interactive plotting editor for generating publication-quality visualizations. Available as a standalone desktop application and an enterprise edition for centralized server deployment, OmnibusX ensures all data processing is conducted locally, eliminating external data transfer and usage tracking. By lowering technical barriers and enhancing reproducibility, OmnibusX aims to accelerate biological discovery and foster robust, data-driven collaborations. A fully documented trial version is accessible at: https://omnibusx.com/apps.","NA","biorxiv",1749593357929
"Skeletal muscle properties in long COVID and ME/CFS differ from those induced by bed rest","10.1101/2025.05.02.25326885","medrxiv",817.2800000000029,9.08,18.93,37.879999999999995,120.38000000000004,"Charlton, B. T.; Slaghekke, A.; Appelman, B.; Eggelbusch, M.; Huijts, J. Y.; Noort, W.; Hendrickse, P. W.; Bloemers, F. W.; Posthuma, J. J.; van Amstel, P.; Goulding, R. P.; Degens, H.; Jaspers, R. T.; van Vugt, M.; Wust, R.","Rob Wust","Vrije Universiteit Amsterdam","2025-05-06","1","PUBLISHAHEADOFPRINT","cc_by_nd","infectious diseases","https://www.medrxiv.org/content/early/2025/05/06/2025.05.02.25326885.source.xml","Patients with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suffer from a reduced exercise capacity, skeletal muscle abnormalities and post-exertional malaise (PEM), where symptoms worsen with cognitive or physical exertion. PEM often results in avoidance of physical activity, resulting in a lower aerobic fitness, which may contribute to skeletal muscle abnormalities. Here, we compared whole-body exercise responses and skeletal muscle adaptations after strict 60-day bed rest in healthy people with those in patients with long COVID and ME/CFS, and healthy age- and sex-matched controls. Bed rest altered the respiratory and cardiovascular responses to (sub)maximal exercise, while patients exhibited respiratory alterations only at submaximal exercise. Bed rest caused muscle atrophy, and the reduced oxidative phosphorylation related to reductions in maximal oxygen uptake. Patients with long COVID and ME/CFS did not have muscle atrophy, but had less capillaries and a more glycolytic fibers, none of which were associated with maximal oxygen uptake. While the whole-body aerobic capacity is similar following bed rest compared to patients, the skeletal muscle characteristics differed, suggesting that physical inactivity alone does not explain the lower exercise capacity in long COVID and ME/CFS.","NA","medrxiv",1749593357929
"Membrane phosphoinositides allosterically tune Î²-arrestin dynamics to facilitate GPCR core engagement","10.1101/2025.06.06.658200","biorxiv",9.55,9.05,9.55,9.55,9.55,"Janetzko, J.; Deutsch, J.; Shi, Y.; Siepe, D. H.; Masureel, M.; Liu, W.; Viner, R.; Inoue, A.; Kobilka, B. K.; Shivnaraine, R. V.","Brian K Kobilka","Stanford University School of Medicine","2025-06-09","1","new results","cc_by_nc_nd","biophysics","https://www.biorxiv.org/content/early/2025/06/09/2025.06.06.658200.source.xml","Arrestin proteins bind active G protein-coupled receptors (GPCRs) through coordinated protein-protein, protein-phosphate, and protein-lipid interactions to attenuate G protein signaling and promote GPCR internalization and trafficking. While there are hundreds of diverse GPCRs, only two {beta}-arrestin isoforms ({beta}arrs) must recognize and engage this wide range of receptors with varied phosphorylation patterns. Traditional models suggest that {beta}arr activation requires displacement of its autoinhibitory C-tail by a phosphorylated GPCR C-terminus; however, this paradigm fails to explain how minimally phosphorylated GPCRs still complex with {beta}arrs. Using single-molecule F&oumlrster resonance energy transfer imaging and hydrogen-deuterium exchange mass spectrometry, we observe basal dynamics in which the {beta}arr1 C-tail spontaneously releases from the N-domain, transiently adopting an active conformation that can facilitate binding of the phosphorylated GPCR C-terminus. We further demonstrate the importance of an intermediate state of {beta}arr1 arising from spontaneous C-tail release stabilized by the membrane phosphoinositide PI(4,5)P2. Both PI(4,5)P2 and mutations in the proximal or middle regions of the C-tail shift {beta}arr1 towards a partially released state, revealing an allosteric connection that informs a refined model for {beta}arr activation. In this model, membrane engagement conformationally primes {beta}arrs prior to receptor binding, thereby explaining how {beta}arrs are recruited by diverse GPCRs, even those with limited C-terminal phosphorylation.","NA","biorxiv",1749593357929
"The structural basis of cold sensitivity","10.1101/2025.06.06.658377","biorxiv",12.399999999999999,8.299999999999999,12.399999999999999,12.399999999999999,12.399999999999999,"Choi, K. Y.; Lin, X.; Cheng, Y.; Julius, D.","David Julius","University of California, San Francisco (UCSF)","2025-06-08","1","new results","cc_by_nc_nd","biophysics","https://www.biorxiv.org/content/early/2025/06/08/2025.06.06.658377.source.xml","Thermosensitive TRP ion channels enable somatosensory nerve fibers to detect changes in our thermal environment over a wide physiologic range. In mammals, the menthol receptor, TRPM8, is activated by temperatures below ~26{degrees}C and is essential for the perception of cold or chemical cooling agents. A fascinating, yet still unachieved goal is to elucidate structural mechanisms whereby TRPM8 or other thermosensitive channels are gated by changes in ambient temperature. Recent studies using cryogenic electron microscopy (cryo-EM) have attempted to address this challenging question but are limited by difficulties in visualizing temperature-evoked conformational substates or assessing the energetic landscape governing gating transitions. Here, we close this gap by using cryo-EM to visualize TRPM8 channels in cellular membranes, where bona fide menthol- and cold-evoked open states are captured. We identify a novel semi-swapped architecture in which interdigitation of channel subunits is substantially rearranged following repositioning of the S6 transmembrane helix and elements of the pore region. By combining this structural analysis with thermodynamic measurements using hydrogen-deuterium exchange mass spectrometry (HDX-MS), we are able to pinpoint the pore and TRP helices as key regions undergoing stimulus-evoked conformational dynamics that drive channel gating. Structural mechanisms associated with activation are validated by comparison of human TRPM8 with the menthol-sensitive, but relatively cold-insensitive avian orthologue. We propose a free energy landscape to explain channel gating by cold or cooling agents.","NA","biorxiv",1749593357929
"Respiratory coordination of excitability states across the human wake-sleep cycle","10.1101/2025.06.03.657770","biorxiv",11.7,8.25,11.7,11.7,11.7,"Sanchez Corzo, A.; Bullon Tarraso, E.; Saltafossi, M.; Berther, T.; Staudigl, T.; Kluger, D. S.; Schreiner, T.","Daniel S. Kluger","University of Muenster","2025-06-07","1","new results","cc_by","neuroscience","https://www.biorxiv.org/content/early/2025/06/07/2025.06.03.657770.source.xml","While the respiratory rhythm is increasingly recognized as a key modulator of oscillatory brain activity across the wake-sleep cycle in humans, very little is known about its influence on aperiodic brain activity during sleep. This broadband activity indicates spontaneous fluctuations in excitation-inhibition (E:I) balance across vigilance states and has recently been shown to systematically covary across the respiratory cycle during waking resting state. We used simultaneous EEG and respiratory recordings over a full night of sleep collected from N = 23 healthy participants to unravel the nested dynamics of respiration phase-locked excitability states across the wake-sleep cycle. We demonstrate a prominent phase shift in the coupling of aperiodic brain activity to respiratory rhythms as participants were transitioning from wakefulness to sleep. Moreover, respiration-brain coupling became more consistent both across and within participants, as interindividual as well as intraindividual variability systematically lessened from wakefulness and the transition to sleep towards deeper sleep stages. Our results suggest that respiration phase-locked changes in E:I balance conceivably add to sleep stage-specific neural signatures of REM and NREM sleep, highlighting the complexity of brain-body coupling during sleep.","NA","biorxiv",1749593357929
"Focus on single gene effects limits discovery and interpretation of complex trait-associated variants","10.1101/2025.06.06.658175","biorxiv",54.65000000000003,7.949999999999999,45.50000000000002,54.65000000000003,54.65000000000003,"Lawrence, K. A.; Gjorgjieva, T.; Montgomery, S. B.","Stephen B Montgomery","Stanford University","2025-06-06","1","new results","cc_by_nc","genetics","https://www.biorxiv.org/content/early/2025/06/06/2025.06.06.658175.source.xml","Standard QTL mapping approaches consider variant effects on a single gene at a time, despite abundant evidence for allelic pleiotropy, where a single variant can affect multiple genes simultaneously. While allelic pleiotropy describes variant effects on both local and distal genes or a mixture of molecular effects on a single gene, here we specifically investigate allelic expression ""proxitropy"": where a single variant influences the expression of multiple, neighboring genes. We introduce a multi-gene eQTL mapping framework--cis-principal component expression QTL (cis-pc eQTL or pcQTL)--to identify variants associated with shared axes of expression variation across a cluster of neighboring genes. We perform pcQTL mapping in 13 GTEx human tissues and discover novel loci undetected by single-gene approaches. In total, we identify an average of 1396 pcQTLs/tissue, 27% of which were not discovered by single-gene methods. These novel pcQTL colocalized with an additional 142 GWAS trait-associated variants and increased the number of colocalizations by 34% over single-gene QTL mapping. These findings highlight that moving beyond single-gene-at-a-time approaches toward multi-gene methods can offer a more comprehensive view of gene regulation and complex trait-associated variation.","NA","biorxiv",1749593357929
"A novel self-organizing embryonic stem cell system reveals the role of Wnt signaling parameters in anterior-posterior patterning of the nervous system","10.1101/2025.06.07.658391","biorxiv",8.45,7.699999999999999,8.45,8.45,8.45,"Du, S.; Warmflash, A.","Aryeh Warmflash","Rice University","2025-06-09","2","new results","cc_by_nc","developmental biology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.07.658391.source.xml","A Wnt activity gradient is essential for the formation of the anterior-posterior (AP) axis in all vertebrates. The relationship between the dynamics of Wnt signaling and specification of AP coordinates is difficult to study in mammalian embryos due to the inaccessibility of developing embryos and the difficulty of live imaging. Here, we developed an \textit{in vitro} model of human neuroectoderm patterning, where the anterior-posterior axis self-organizes along the radius of a micropatterned human pluripotent stem cell colony. We used this system to study the quantitative relationship between Wnt signaling in space and time and the resulting AP patterns. We found that rather than a smoothly varying gradient along the axis, signaling is elevated in midbrain compared to either surrounding region. The timing, rather than the amplitude or duration, of the Wnt response played the most important role in setting axial coordinates. These results establish a simple system for studying the patterning of the human nervous system and elucidate how cells interpret Wnt dynamics to determine their position along the AP axis.","NA","biorxiv",1749593357929
"Molecular and functional dissection using CaMPARI-seq reveals the neuronal organization for dissociating optic flow-dependent behaviors","10.1101/2025.06.04.654794","biorxiv",8.55,7.3,8.55,8.55,8.55,"Matsuda, K.; Wang, C.-H.; Toyoda, A.; Shiraki, T.; Kawakami, K.; Kubo, F.","Fumi Kubo","RIKEN Center for Brain Science, National Institute of Genetics, Japan","2025-06-08","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2025/06/08/2025.06.04.654794.source.xml","Optic flow processing is critical for the visual control of body and eye movements in many animals. Rotational and translational binocular optic flow patterns need to be clearly distinguished to induce different behavior outputs. However, the specific neuron types and their connectivity involved in this computation remain unclear. Here, we developed a method to link the functional labeling using a photoconvertible calcium indicator called CaMPARI2 and single-cell RNA-sequencing (CaMPARI-seq) to investigate the transcriptional profile of the pretectum, a center for processing optic flow in larval zebrafish. Using this technique, we identified a pretectal cluster expressing tcf7l2, which can be further classified into molecularly distinct subclusters. In vivo calcium imaging and cell ablation revealed that nkx1.2lb-positive pretectal neurons are commissural inhibitory neurons required for the optomotor response but not for the optokinetic response. Our genetic and functional dissection using CaMPARI-seq uncovered the neuronal organization essential for dissociating different optic flow-dependent behaviors.","NA","biorxiv",1749593357929
"Structures of EHD2 filaments on curved membranes provide a model for caveolar neck stabilization","10.1101/2025.06.05.658037","biorxiv",29.400000000000006,7.25,29.400000000000006,29.400000000000006,29.400000000000006,"Vazquez-Sarandeses, E.; Mikirtumov, V.; Noel, J. K.; Kudryashev, M.; Daumke, O.","Oliver Daumke","Max-Delbrueck-Center for Molecular Medicine","2025-06-07","1","new results","cc_by_nd","molecular biology","https://www.biorxiv.org/content/early/2025/06/07/2025.06.05.658037.source.xml","Caveolae are flask-shaped invaginations of the plasma membrane serving critical functions in mechano-protection and signal transduction. Caveolar dynamics, such as movement within the plasma membrane or endocytosis, relies on precise shaping of the highly curved caveolar necks. The dynamin-like EHD2 ATPase is proposed to form an oligomeric scaffold around the caveolar neck, but its detailed molecular action is poorly understood. Here, we employed cryo-electron tomography to elucidate structures of EHD2 filaments oligomerized on tubulated liposomes. EHD2 filaments form a highly curved membrane scaffold which stabilizes a sophisticated tubular membrane geometry with undulations along the tubes axis. An amino-terminal sequence facilitates this geometry by inserting into the membrane, thereby acting as a spacer between adjacent filaments. Moreover, in endothelial cells lacking EHD2, caveolar necks become narrower and elongated. Our structural work provides the molecular framework for understanding EHD2 scaffold formation and its cellular function in caveolar dynamics.","NA","biorxiv",1749593357929
"Rapid transcriptional response to a dynamic morphogen by time integration","10.1101/2025.06.09.658715","biorxiv",7.1499999999999995,7.1499999999999995,7.1499999999999995,7.1499999999999995,7.1499999999999995,"Brantley, S. E.; Janssen, J.; Chao, A.; Vergassola, M.; Blythe, S. A.; Di Talia, S.","Stefano Di Talia","Duke University Medical Center","2025-06-09","1","new results","cc_by_nc_nd","developmental biology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.09.658715.source.xml","During development, cells must interpret extracellular signals with speed and accuracy. While morphogen gradients pattern tissues, how cells respond to dynamic morphogens remains unclear. Here, we investigate how dorsal patterning in the Drosophila embryo is specified by a rapidly evolving BMP gradient. Using a live reporter of BMP pathway activity and nascent transcription reporters, we find that gene expression is best predicted by time integration of BMP signaling, rather than instantaneous levels. However, in sog mutant embryos with broad BMP activity, integration alone fails to predict gene expression outside the normal domain. We show that the transcription factor Zen lowers the signaling threshold required for activation, enabling integration to drive rapid transcriptional responses even at low BMP levels. Together, these results suggest that cells interpret dynamic morphogen signals through the combined action of temporal integration and spatial competence, providing a framework for robust pattern formation on fast developmental timescales.","NA","biorxiv",1749593357929
"EndoNB: A general strategy to study the internalization of cell surface proteins","10.1101/2025.06.08.658482","biorxiv",6.999999999999999,6.999999999999999,6.999999999999999,6.999999999999999,6.999999999999999,"Lenaerts, A.-S.; Krishtal, J.; Arima, T.; Leskovar, N.; Zeinoddin, N.; Almeida-Souza, L.","Leonardo Almeida-Souza","University of Helsinki","2025-06-08","1","new results","cc_by_nd","cell biology","https://www.biorxiv.org/content/early/2025/06/08/2025.06.08.658482.source.xml","The cell surface harbors thousands of distinct proteins whose function depend on continuous cycles of internalization and replenishment. Disturbances in this turnover are typical hallmarks of many diseases. Yet, tools to study the dynamics of most surface proteins are suboptimal or unavailable. Here, we present a new method that enables the analysis of surface protein turnover of virtually any surface protein at endogenous levels. Our approach combines CRISPR/cas9-mediated genome engineering with a cleavable recombinant probe, which addresses many of the shortcomings of current methodologies. We demonstrate the capabilities our method by studying the internalization behavior of a previously uncharacterized surface protein and by assessing the effect of ligands and activity modulators in the endocytic behavior of established receptors. In summary, our method represents a versatile strategy to explore surface protein biology and enhances our ability to study the mechanisms of membrane protein retrieval and recycling.","NA","biorxiv",1749593357929
"Membranes arrest the coarsening of mitochondrial condensates","10.1101/2025.06.06.658068","biorxiv",10.45,6.799999999999999,10.45,10.45,10.45,"Aththawala Gedara, S. V. B. D.; Penna, S. T.; Feric, M.","Marina Feric","Penn State University","2025-06-09","1","new results","cc_no","cell biology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.06.658068.source.xml","Mitochondria contain double membranes that enclose their contents. Within their interior, the mitochondrial genome and its RNA products are condensed into ~100 nm sized (ribo)nucleoprotein complexes. How these endogenous condensates maintain their roughly uniform size and spatial distributions within membranous mitochondria remains unclear. Here, we engineered an optogenetic tool (mt-optoIDR) that allowed for controlled formation of synthetic condensates upon light activation in live mitochondria. Using live cell super-resolution microscopy, we visualized the nucleation of small, yet elongated condensates (mt-opto-condensates), which recapitulated the morphologies of endogenous mitochondrial condensates. We decoupled the contribution of the double membranes from the environment within the matrix by overexpressing the dominant negative mutant of a membrane fusion protein (Drp1K38A). The resulting bulbous mitochondria had significantly more dynamic condensates that coarsened into a single, prominent droplet. These observations inform how mitochondrial membranes can limit the growth and dynamics of the condensates they enclose, without the need of additional regulatory mechanisms.","NA","biorxiv",1749593357929
"JIP4 deficiency causes a novel lysosome storage disease arising from impaired cystine efflux","10.1101/2025.06.06.657909","biorxiv",6.800000000000001,6.800000000000001,6.800000000000001,6.800000000000001,6.800000000000001,"Nassar, L. M.; Shi, x.; Roczniak-Ferguson, A.; Shen, H.; Ferguson, S. M.","Shawn M Ferguson","Yale University","2025-06-09","1","new results","cc_by","cell biology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.06.657909.source.xml","Lysosomes break down macromolecules, clear cellular waste and recycle nutrients such as cystine. We describe a novel mechanism whereby JIP4 regulates lysosomal cystine storage by controlling the abundance of cystinosin (CTNS), the transporter responsible for lysosomal cystine efflux. To this end, JIP4, previously characterized as a motor adaptor and kinase signaling scaffold, suppresses TMEM55B-dependent ubiquitylation of CTNS. Loss of JIP4 reduces CTNS protein levels, leading to lysosomal cystine accumulation and lysosomal storage defects that phenocopy loss of CTNS in both human cells and the renal proximal tubules of JIP4 knockout mice. These phenotypes mirror cystinosis, the lysosomal storage disease caused by CTNS loss-of-function. Our findings thus reveal a fundamental process that controls the efflux of lysosomal cystine and has relevance to understanding human disease arising from JIP4 mutations.","NA","biorxiv",1749593357929
"Base Editing Gene Therapy for Heterozygous Familial Hypercholesterolemia","10.1101/2025.04.17.25325983","medrxiv",76.576,6.25,6.25,68.25,68.25,"Wan, P.; Tang, S.; Lin, D.; Lu, Y.; Long, M.; Xiao, L.; Jiang, Y.; Liao, J.; Ma, X.; Liu, Y.; Yu, W.; Wang, Z. J.; Wu, Y.; Yang, T.; Xia, Q.","Qiang Xia","Department of Liver Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, 1630 Dongfang Road, Shanghai, 200127, China","2025-04-25","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","cardiovascular medicine","https://www.medrxiv.org/content/early/2025/04/25/2025.04.17.25325983.source.xml","BackgroundHeterozygous familial hypercholesterolemia (HeFH) is a genetic disorder characterized by persistently elevated low-density lipoprotein cholesterol (LDL-C) levels, leading to an increased risk of early-onset atherosclerosis cardiovascular diseases (ASCVD). YOLT-101, an in vivo base-editing therapeutic agent delivered via GalNAc-modified lipid nanoparticles, is designed to achieve permanent inactivation of proprotein convertase subtilisin/kexin type 9 (PCSK9), enabling sustained LDL-C reduction.

MethodsThis trial enrolled participants with heterozygous genetic mutations in the low-density lipoprotein receptor (LDLR), and LDL-C levels of [&ge;]2.6 mmol/L (without ASCVD) or [&ge;]1.8 mmol/L (with ASCVD) despite receiving moderate- or high-intensity statin therapy. Eligible patients received a single intravenous infusion of YOLT-101 at ascending doses (0.2, 0.4, and 0.6 mg/kg). We report interim results from an ongoing clinical trial evaluating the safety, tolerability, pharmacodynamics, and efficacy of YOLT-101.

ResultsSix participants were enrolled (median age, 48 years, range, 34-62) in the study. The most common adverse events (AEs) were transient infusion-related reactions (83.3%) and elevations in alanine/aspartate aminotransferase (50%). No study withdrawals or AEs of grade 3 or higher occurred. PCSK9 and LDL-C levels decreased in a dose-dependent manner following YOLT-101 administration. In the 0.6mg/kg group (n=3), mean PCSK9 levels decreased by 55.9% at week 1 and by 75.8% and 72.5% after 1 and 4 months, respectively; corresponding LDL-C reductions were 33.2%, 48.9%, and 50.4%, respectively.

ConclusionsA single infusion of YOLT-101 at 0.6 mg/kg was well tolerated and led to sustained PCSK9 and LDL-C reduction, demonstrating promise for future clinical development. (Funded by YolTech Therapeutics; Registration Number: NCT06458010)","NA","medrxiv",1749593357929
"Polypore Mushroom Mycelia as an Adjunct to COVID-19 Vaccination: A Randomized Clinical Trial","10.1101/2025.06.06.25327723","medrxiv",6.6,6.1,6.6,6.6,6.6,"Saxe, G.; Smith, C. N.; Golshan, S.; Shekhtman, T.; Bair, Z. J.; Beathard, C.; Davis, R. A.; MacElhern, L.; Shubov, A.; Slater, D.; Kao, L. K.; Senowitz, P.; Wilson, S.","Gordon Saxe","University of California San Diego","2025-06-08","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","infectious diseases","https://www.medrxiv.org/content/early/2025/06/08/2025.06.06.25327723.source.xml","Use of fungal mycelium as a vaccination adjunct may constitute a novel antiviral strategy to address newly emerging viruses. In a randomized, double-blind, placebo-controlled clinical trial, we evaluated safety and feasibility of fungal mycelium (Fomitopsis officinalis and Trametes versicolor, FoTv) as an adjunct to human COVID-19 vaccination, as well as its impact on vaccine side-effects and anti-SARS-CoV-2 antibodies (Abs). We evaluated safety, feasibility, vaccine side-effects (across 5 days), and anti-SARS-CoV-2 Ab levels (across 6 months). Safety metrics were similar for the FoTv (N=52) and Placebo (N=38) groups and the approach was feasible. Participants with detectable Abs (from prior COVID antigen exposure) were classified as ""COVID-Exposed"" and those with undetectable Abs as ""COVID-Naive."" FoTv, versus Placebo, significantly reduced side-effects in COVID-Naive, but not in COVID-Exposed individuals. In the COVID-Naive FoTv group, Ab responses were preserved across 6 months, an effect not observed among other groups. Adjunctive FoTv was safe, feasible, and reduced vaccine side-effects without compromising (and possibly increasing) Ab levels up to 6 months in participants without previous SARS-CoV-2 exposure. Use of fungal mycelia was successfully tested as an approach to prevent a novel pandemic virus (SARS-CoV-2), with potential application to H5N1/Bird Flu and other emerging viruses.","NA","medrxiv",1749593357929
"The anti-neural role of BMP signaling is a side effect of its global function in dorsoventral patterning","10.1101/2025.06.08.658475","biorxiv",11.049999999999997,5.6,11.049999999999997,11.049999999999997,11.049999999999997,"Knabl, P.; Ordonez, J. F.; Montenegro Cabrera, J. D.; Wollesen, T.; Genikhovich, G.","Grigory Genikhovich","University of Vienna","2025-06-08","1","new results","cc_by","developmental biology","https://www.biorxiv.org/content/early/2025/06/08/2025.06.08.658475.source.xml","In Bilateria with centralized nervous systems (e.g. in vertebrates or arthropods), the minimum of the BMP signaling activity gradient defines the position of the central nervous system. BMP-dependent patterning of the secondary body axis is ancestral for Bilateria and possibly also for the bilaterian sister clade Cnidaria. However, the variety of levels of centralization of the nervous systems in Bilateria - from diffuse to fully centralized - as well as the lack of centralization of the nervous system in Cnidaria, suggest that BMP signaling cannot be perceived as a universally ""anti-neural"" signal. Here we use transgenic reporter lines in the anthozoan cnidarian Nematostella to show that BMP signaling is active in distinct neuronal populations. Moreover, attenuation of BMP signaling followed by RNA-Seq shows that BMP signaling is a positive regulator of many neuronal genes, including the top-tier neural progenitor marker soxB(2). Further, we analyze BMP signaling activity in the true jellyfish Aurelia and box jellyfish Tripedalia proving that BMP signaling in the diffuse cnidarian nervous system is not an anthozoan but an ancestral cnidarian feature, shared by anthozoans and medusozoans. Finally, we show that the highly centralized ventral nervous system of the non-model spiralian, the chaetognath Spadella, forms out of paired BMP signaling-positive domains on the lateral sides of the embryo. Together, our data suggest that one of the ancestral roles of BMP signaling was in promoting neurogenesis. We propose that the ""anti-neural"" function of BMP signaling in vertebrates and arthropods is a side effect of its global role in the dorsoventral patterning of the ectoderm.","NA","biorxiv",1749593357929
"Pan-angiosperm analysis of the CLE signaling peptide family unveils paths, patterns, and predictions of paralog diversification","10.1101/2025.06.04.657892","biorxiv",5.6,5.6,5.6,5.6,5.6,"Gentile, I.; Santo Domingo, M.; Zebell, S. G.; Fitzgerald, B.; Lippman, Z.","Zachary Lippman","Howard Hughes Medical Institute/Cold Spring Harbor Laboratory","2025-06-09","2","new results","cc_no","plant biology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.04.657892.source.xml","The compositions of conserved gene families often vary widely between species, complicating predictions and experimental tests of shared versus distinct functions, especially in families shaped by extensive duplication, redundancy, and paralog diversification. The plant CLV3/EMBRYO-SURROUNDING REGION (CLE) small-signaling peptide family exemplifies these challenges. Although genetic studies in model systems have identified shared roles for a few CLE genes and species-specific redundancies, an evolutionary analysis of the entire family over deep time could empower predictive and experimental dissections of functions obscured by redundancy. We developed a scanning pipeline that de novo annotated CLE genes from 2,000 genomes representing 1,000 species, uncovering thousands of previously undetected family members and producing a comprehensive phylogenetic reconstruction and tracing of the family's evolution and sequence diversification over 140 million years. Computational modeling of coding and cis-regulatory regions predicted lineage-specific asymmetries in paralog redundancy, stemming from ancestral amino acids in the functional core of the dodecapeptide and partial conservation of promoter elements. We tested these predictions using two genome-editing strategies in Solanaceae. Base-editing of deeply conserved residues in the CLV3 dodecapeptide and its paralogs across three species confirmed their critical roles in repressing stem-cell proliferation, and multiplex CRISPR knockouts of the 52 tomato CLE genes resolved pairwise and higher-order redundancies, revealing previously uncharacterized regulators of shoot architecture and plant size. These findings show how both peptide and cis-regulatory erosion shape CLE redundancy and provide a framework for detecting and translating deep evolutionary signals into testable genetic hypotheses across compositionally complex gene families.","NA","biorxiv",1749593357929
"Integrative analysis of mRNA stability regulation uncovers a metastasis-suppressive program in breast cancer","10.1101/2025.06.06.658309","biorxiv",14.549999999999999,5.55,13.799999999999999,14.549999999999999,14.549999999999999,"Karner, H.; Mittmann, T. C.; Chen, V. W.; Borah, A. A.; Langen, A.; Yousefi, H.; Fish, L.; Zaro, B. W.; Navickas, A.; Goodarzi, H.","Hani Goodarzi","Department of Biochemistry & Biophysics, University of California San Francisco, San Francisco, CA, USA","2025-06-07","1","new results","cc_by_nc","cancer biology","https://www.biorxiv.org/content/early/2025/06/07/2025.06.06.658309.source.xml","Heterogeneity in cancer gene expression is typically linked to genetic and epigenetic alterations, yet post-transcriptional regulation likely influences these patterns as well. However, the quantitative contribution of post-transcriptional mechanisms to cancer transcriptome dynamics remains unclear. Here, we systematically measured mRNA dynamics across diverse breast cancer models, revealing that mRNA stability significantly shapes gene expression variability. To decipher the regulatory grammar underlying these dynamics, we developed GreyHound, an interpretable multimodal deep-learning framework integrating RNA sequence features and RNA-binding protein (RBP) expression. GreyHound identified an extensive network of RBPs and their regulons underlying variations in mRNA stability. Among these, we uncovered a metastasis-suppressive regulatory axis centered on the RNA-binding protein RBMS3 and its post-transcriptional control of the redox regulator TXNIP. Functional and molecular analyses revealed that RBMS3 depletion resulted in targeted transcript destabilization, which was associated with poor clinical outcomes and enhanced metastatic potential in xenograft models. Using in vivo epistasis studies, we confirmed that RBMS3 regulation of TXNIP mRNA stability drives this metastasis-suppressive program. These findings position the RBMS3-TXNIP regulatory axis as a key post-transcriptional mechanism in breast cancer and illustrate how interpretable models of RNA dynamics can uncover hidden regulatory programs in disease.","NA","biorxiv",1749593357929
"Childhood Maltreatment and Deviations from Normative Brain Structure: Results from 3,711 Individuals from the ENIGMA MDD and ENIGMA PTSD","10.1101/2025.06.04.657717","biorxiv",5.45,5.45,5.45,5.45,5.45,"Wang, H. R.; ENIGMA MDD Working Group and ENIGMA PTSD Working Group,  ; Ho, T. C.","Tiffany C Ho","University of California, Los Angeles","2025-06-09","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2025/06/09/2025.06.04.657717.source.xml","Childhood maltreatment (CM), encompassing abuse and neglect, affects over two-thirds of the general population and increases risk for stress-related psychopathology, including major depressive disorder (MDD) and posttraumatic stress disorder (PTSD). The extent to which neuroanatomical alterations in MDD and PTSD are attributable to CM, however, is uncertain. Here, we analyzed CM and 3D structural brain MRI data from 3,711 participants in the ENIGMA MDD and PTSD Working Groups (25 sites; 33.3+/-13.0 years; 59.9% female). Normative modeling estimated deviation z-scores for 14 subcortical volumes (SV), 68 cortical thickness (CT), and 68 surface area (SA) measures, capturing differences from population norms. Transdiagnostic associations between CM and brain deviation scores were evaluated within each sex and age cohort. In young adults (ages 18-35), abuse was associated with larger volumes in thalamus and pallidum, thinner isthmus cingulate and middle frontal regions, and thicker medial orbitofrontal cortex; there were no significant effects in pediatric ([&le;]18 years) participants. The strongest effects were observed in young female adults (|{beta}|=.07-.22, q<.05): greater abuse and neglect were correlated with smaller hippocampus and putamen volumes, thinner entorhinal cortex, and smaller SA in fusiform/inferior parietal regions, and with larger SA in orbitofrontal and occipital cortices. In males, abuse had widespread effects on CT and SA (|{beta}|=.1-.18, q<.05); effects for neglect were minimal. Our findings of age- and sex-specific instantiations of CM on brain morphometry highlight the importance of developmental context in understanding how adverse experiences shape neurobiological vulnerability to MDD and PTSD.","NA","biorxiv",1749593357929
"Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis","10.1101/2025.06.03.657464","biorxiv",18.499999999999996,5.300000000000001,18.499999999999996,18.499999999999996,18.499999999999996,"Bhalerao, N. U.; Ogoti, Y.; Peura, J.; Johnson, C.; Chen, Q.; Korobkina, E.; Keller, F.; Wengyn, M.; Norgard, R. J.; Shamber, C.; Klute, K.; DiMaio, D.; Sellin, K.; Grandgenett, P. M.; Li, R.; Hollingsworth, M. A.; GUILHERME, A.; Czech, M.; Kremer, R.; Zhu, L. J.; Watson, E. V.; Ruscetti, M.; Guertin, D.; Pitarresi, J. R.","Jason R Pitarresi","University of Massachusetts Medical School","2025-06-07","1","new results","cc_by_nc_nd","cancer biology","https://www.biorxiv.org/content/early/2025/06/07/2025.06.03.657464.source.xml","Pancreatic cancer patients have the highest rates and most severe forms of cancer cachexia, yet cachexia etiologies remain largely elusive, leading to a lack of effective intervening therapies. PTHrP has been clinically implicated as a putative regulator of cachexia, with serum PTHrP levels correlating with increased weight loss in PDAC patients. Here we show that cachectic PDAC patients have high expression of tumor PTHrP and use a genetically engineered mouse model to functionally demonstrate that deletion of Pthlh (encoding the PTHrP protein) blocks cachectic wasting, dramatically extending overall survival. The re-expression of PTHrP in lowly cachectic models is sufficient to induce wasting and reduce survival in mice, which is reversed by the conditional deletion of the PTHrP receptor, Pth1r, in adipocytes. Mechanistically, tumor-derived PTHrP suppresses de novo lipogenesis in adipocytes, leading to a molecular rewiring of adipose depots to promote wasting in the cachectic state. Finally, the pharmacological disruption of the PTHrP-PTH1R signaling axis abrogates wasting, highlighting that a targeted disruption of tumor-adipose crosstalk is an effective means to limit cachexia.

STATEMENT OF SIGNIFICANCEPancreatic ductal adenocarcinoma (PDAC) is the prototypical cancer type associated with cancer cachexia, a debilitating wasting syndrome marked by adipose tissue loss and muscle atrophy. Herein, we establish that PTHrP is a tumor-derived factor that facilitates cachexia by downregulating de novo lipogenesis in adipocytes and that blocking PTHrP is an effective means to limit wasting in preclinical mouse models.","NA","biorxiv",1749593357929
"Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida","10.1101/2025.04.25.25326460","medrxiv",736.4500000000038,1.5,25.000000000000004,27.500000000000007,145.19999999999976,"Levi, R.; Mansuri, F.; Jordan, M.; Ladapo, J.","Retsef Levi","MIT","2025-04-29","1","PUBLISHAHEADOFPRINT","cc_by","public and global health","https://www.medrxiv.org/content/early/2025/04/29/2025.04.25.25326460.source.xml","ObjectiveTo examine the relative impact of the initial series of the messenger RNA (mRNA) BNT162b2 (Pfizer) and mRNA-1273 (Moderna) on all-cause and non-COVID-19 mortality among Florida residents.

DesignMatched cohort with cumulative and adjusted assessments of risk over 12 month follow up.

SettingFloridas state-level public health databases with records about COVID-19 vaccination, sociodemographic characteristics of vaccine recipients, location of vaccination, and vital statistics.

ParticipantsMatched cohort of 1,470,100 noninstitutionalized adult Florida residents receiving at least two doses, less than six weeks apart, of either the BNT162b2 or mRNA-1273 mRNA vaccine between December 18, 2020, and August 31, 2021.

InterventionInitial vaccination with two doses of either BNT162b2 or mRNA-1273

Main outcome measuresAll-cause, cardiovascular, COVID-19, and non-COVID-19 mortality within 12 months after the second COVID-19 vaccine dose

ResultsThere were 9,162,484 noninstitutionalized adult Florida residents who met inclusion criteria, including 5,328,226 BNT162b2 vaccine recipients and 3,834,258 mRNA-1273 vaccine recipients. A total of 1,470,100 vaccinees were matched 1-to-1 based on seven criteria, including census tract. Compared with mRNA-1273 recipients, BNT162b2 recipients had significantly higher risk for all-cause mortality (847.2 vs. 617.9 deaths per 100,000; odds ratio, OR [95% CI]: 1.384 [1.331, 1.439]), cardiovascular mortality (248.7 vs. 162.4 deaths per 100,000 persons; OR [95% CI]: 1.540 [1.431, 1.657]), COVID-19 mortality (55.5 vs. 29.5 deaths per 100,000 persons; OR [95% CI]: 1.882 [1.596, 2.220]) and non-COVID-19 mortality (791.6 vs. 588.4 deaths per 100,000 persons; OR [95% CI]: 1.356 [1.303, 1.412]). Negative control outcomes did not show any indication of meaningful unobserved residual confounding.

ConclusionFlorida adults who received BNT162b2 had significantly higher risk of 12-month all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to matched mRNA-1273 recipients. These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Summary boxesO_ST_ABSWhat is already known on this topicC_ST_ABSO_LIVaccines may have health effects beyond the diseases they target, including potential effects on all-cause mortality.
C_LIO_LIThe relative impact of the initial series of the messenger RNA (mRNA) BNT162b2 (Pfizer) and mRNA-1273 (Moderna) on all-cause and non-COVID-19 mortality is not well-studied.
C_LI

What this topic addsO_LIFlorida adults who received BNT162b2 had significantly higher risk of 12-month all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to carefully matched mRNA-1273 recipients.
C_LIO_LIThese findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality.
C_LI","NA","medrxiv",1749593357929
"Elucidating the mechanisms of action and evolutionary history of phage anti-defence proteins","10.1101/2025.06.06.658234","biorxiv",20.399999999999995,4.800000000000001,20.399999999999995,20.399999999999995,20.399999999999995,"Murtazalieva, K.; Karatzas, E.; Corona, F.; Wang, J.; Typas, A.; Finn, R. D.","Robert D. Finn","European Bioinformatics Institute","2025-06-06","1","new results","cc_by_nc_nd","microbiology","https://www.biorxiv.org/content/early/2025/06/06/2025.06.06.658234.source.xml","Phages and bacteria are locked in a molecular arms race, with phage anti-defence proteins (ADPs) enabling them to evade bacterial immune systems. To streamline access to information on ADPs, we developed the Encyclopaedia of Viral Anti-DefencE Systems (EVADES), an online resource containing sequences, structures, protein family annotations, and mechanisms of action (MoA) for 257 ADPs. Through computational structural analysis we established putative MoAs for 21 uncharacterised ADPs. We demonstrate the utility of EVADES by exploring three hypotheses and demonstrate that: (i) ADPs acting as DNA mimics exhibit broad-spectrum activity against defences; (ii) protein sharing across defence systems enables multi-defence inhibitory activity of ADPs; and (iii) eukaryotic dsDNA viruses encode ADP homologs, suggesting conserved immune evasion strategies across domains. These results highlight the broader relevance of phage ADPs in understanding interactions between prokaryotic or eukaryotic viruses and their hosts. EVADES is freely accessible at https://www.ebi.ac.uk/finn-srv/evades.

HighlightsO_LIThe EVADES database aggregates knowledge on phage anti-defence proteins (ADPs), facilitating hypothesis generation.
C_LIO_LIMechanisms of action are proposed for 21 uncharacterised ADPs.
C_LIO_LIADPs that function as DNA mimics exhibit broad-spectrum activity, blocking or triggering diverse bacterial defence systems.
C_LIO_LIShared bacterial defence targets and functions underpin the multi-defence capabilities of ADPs and enable the prediction of additional targets.
C_LIO_LIEukaryotic double-stranded DNA viruses employ functional homologs of ADPs to evade host immune responses.
C_LI","NA","biorxiv",1749593357929
"Convergent and divergent brain-cognition relationships during development revealed by cross-sectional and longitudinal analyses in the ABCD Study","10.1101/2025.06.06.658294","biorxiv",15.249999999999998,2.2,15.249999999999998,15.249999999999998,15.249999999999998,"Xie, Y.; Zhang, S.; Orban, C.; Ooi, L. Q. R.; Kong, R.; Floris, D. L.; Zuo, X.-N.; Dhamala, E.; Holmes, A. J.; Uddin, L. Q.; Nichols, T. E.; Di Martino, A.; Yeo, B. T. T.","Thomas Yeo","National University of Singapore","2025-06-09","3","new results","cc_by","neuroscience","https://www.biorxiv.org/content/early/2025/06/09/2025.06.06.658294.source.xml","How brain networks and cognition co-evolve during development remains poorly understood. Using longitudinal data collected at baseline and Year 2 from 2,949 individuals (ages 8.9-13.5) in the Adolescent Brain Cognitive Development (ABCD) Study, we show that baseline resting-state functional connectivity (FC) more strongly predicts future cognitive ability than concurrent cognitive ability. Models trained on baseline FC to predict baseline cognition generalize better to Year 2 data, suggesting that brain-cognition relationships strengthen over time. Intriguingly, baseline FC outperforms longitudinal FC change in predicting future cognitive ability. Differences in measurement reliability do not fully explain this discrepancy: although FC change is less reliable (intraclass correlation, ICC = 0.24) than baseline FC (ICC = 0.56), matching baseline FC reliability by shortening scan time only partially narrows the predictive gap. Furthermore, neither baseline FC nor FC change meaningfully predicts longitudinal change in cognitive ability. We also identify converging and diverging predictive network features across cross-sectional and longitudinal models of brain-cognition relationships, revealing a multivariate twist on Simpsons paradox. Together, these findings suggest that during early adolescence, stable individual differences in brain functional network organization exert a stronger influence on future cognitive outcomes than short-term changes.","NA","biorxiv",1749593357929
"GeneChat: A Multi-Modal Large Language Model for Gene Function Prediction","10.1101/2025.06.05.658031","biorxiv",18.3,1.1,13.45,18.3,18.3,"Dhanasekar, S.; Saranathan, A.; Xie, P.","Pengtao Xie","University of California San Diego","2025-06-06","1","new results","cc_by","bioinformatics","https://www.biorxiv.org/content/early/2025/06/06/2025.06.05.658031.source.xml","Accurately predicting gene function from DNA sequences remains a fundamental challenge in genomics, particularly given the limited experimental annotation available for most genes. Existing computational approaches often formulate function prediction as a classification task over predefined categories, limiting their flexibility and expressiveness. We introduce GeneChat, a multi-modal large language model designed to generate free-form, natural language descriptions of gene functions directly from nucleotide sequences and textual prompts. GeneChat integrates three components: a DNABERT-2-based gene encoder optimized for long-range genomic context, an adaptor that aligns gene representations with the input space of a large language model, and Vicuna-13B, a fine-tuned LLaMA-2 variant used to produce coherent functional narratives. Trained on over 50,000 genes from the NCBI database, GeneChat outperforms GPT-4o on BLEU and METEOR metrics, demonstrating superior ability to generate accurate, context-aware, and semantically rich descriptions. This work highlights the potential of foundation models for advancing interpretable and scalable gene function prediction in a free-form, language-driven paradigm.","NA","biorxiv",1749593357929
"From Tool to Teammate: A Randomized Controlled Trial of Clinician-AI Collaborative Workflows for Diagnosis","10.1101/2025.06.07.25329176","medrxiv",12.45,4.2,12.45,12.45,12.45,"Everett, S. S.; Bunning, B. J.; Jain, P.; Lopez, I.; Agarwal, A.; Desai, M.; Gallo, R.; Goh, E.; Kadiyala, V. B.; Kanjee, Z.; Koshy, J. M.; Olson, A.; Rodman, A.; Schulman, K.; Strong, E.; Chen, J. H.; Horvitz, E. J.","Eric J Horvitz","Office of the Chief Scientific Officer, Microsoft","2025-06-08","1","PUBLISHAHEADOFPRINT","cc_by","health informatics","https://www.medrxiv.org/content/early/2025/06/08/2025.06.07.25329176.source.xml","Early studies of large language models (LLMs) in clinical settings have largely treated artificial intelligence (AI) as a tool rather than an active collaborator. As LLMs now demonstrate expert-level diagnostic performance, the focus shifts from whether AI can offer valuable suggestions to how it can be effectively integrated into physicians diagnostic workflows. We conducted a randomized controlled trial (n=70 clinicians) to evaluate the value of employing a custom GPT system designed to engage collaboratively with clinicians on diagnostic reasoning challenges. The collaborative design began with independent diagnostic assessments from both the clinician and the AI. These were then combined in an AI-generated synthesis that integrated the two perspectives, highlighting points of agreement and disagreement and offering commentary on each. We evaluated two workflow variants: one where the AI provided an initial opinion (AI-first), and another where it followed the clinicians assessment (AI-second). Clinicians using either collaborative workflow outperformed those using traditional tools, achieving average accuracies of 85% (AI-first) and 82% (AI-second), compared to 75% with traditional resources (p < 0.0004 and p < 0.00001; mean differences = 9.8% and 6.8%; 95% CI = 4.6%-15% and 4.0%-9.6%). Performance did not differ significantly between workflows or from the AI-alone score of 90%. These results underscore the value of collaborative AI systems that complement clinician expertise and foster effective coordination between human and machine reasoning in diagnostic decision-making.","NA","medrxiv",1749593357929
"LINE-1 replication in a mouse TDP-43 model of neurodegeneration marks motor cortex neurons for cell-intrinsic and non-cell autonomous programmed cell death.","10.1101/2025.06.06.658329","biorxiv",12.45,1.95,12.45,12.45,12.45,"Korada, S.; Tam, O.; Greco, H.; Gale Hammell, M.; dubnau, j.; Sher, R.","Roger Sher","Stony Brook University","2025-06-07","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2025/06/07/2025.06.06.658329.source.xml","A key pathological feature of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) is the loss of nuclear localization and the accumulation of cytoplasmic inclusions of hyperphosphorylated TAR-DNA binding protein 43 (TDP-43). TDP-43 is a nucleic acid-binding protein involved in transcriptional repression, mRNA splicing, and the regulation of retrotransposable elements (RTEs) and endogenous retroviruses (ERVs). RTEs and ERVs are mobile genetic elements that constitute about 45% of our genome. These virus-like elements encode the capacity to replicate through an RNA intermediate and insert cDNA copies at de novo chromosomal locations. Their expression is a proven source of DNA damage and inflammatory signaling. Research in Drosophila has demonstrated a causal role of RTEs/ERVs in mediating both intracellular toxicity of TDP-43 and the intercellular spread of these toxic effects from glia to neurons. RTEs and ERVs are inappropriately expressed in postmortem tissues from ALS, FTD, and Alzheimers Disease (AD) patients, as well as in cell culture in response to TDP-43 disruption, suggesting that the findings in Drosophila may be conserved across species. But the role of RTEs and ERVs has not yet been examined in a vertebrate model of TDP-43 pathology. To investigate the functional contributions of RTEs in vertebrates, we utilized an established transgenic mouse model that overexpresses moderate levels of either human wild-type TDP-43 (hTDP-43-WT) or a mutant version with a specific causal amino acid substitution (hTDP-43-Q331K) associated with some inherited forms of the disease. Through RNA-sequencing of the motor cortex, and imaging of a LINE-1-EGFP retrotransposon indicator cassette, we found that the TDP-43 transgenic animals exhibit broad expression of RTEs and ERVs, along with replication of LINE-1 in glia and neurons in the motor cortex. This expression begins at the age of onset of neurological phenotypes, earlier in the hTDP-43-Q331K animals and much later in hTDP-43-WT. Although the motor defects progressively worsen over time, the LINE-1-EGFP replication reporter transiently labels spatially clustered groups of neurons and glia at the time of onset of motor symptoms. These EGFP-labeled neurons undergo cell death and are therefore lost over time. Unlabeled cells also die as a function of distance from the clusters of LINE-1-EGFP labeled neurons and glial cells. Together, these findings support the hypothesis that TDP-43 pathology triggers RTE/ERV expression in the motor cortex, that such expression marks cells for programmed cell death, with non-cell autonomous effects on nearby neurons and glial cells.","NA","biorxiv",1749593357929
"Stochastic Misfolding Drives the Emergence of Distinct Î±-Synuclein Strains","10.1101/2025.06.03.657690","biorxiv",10.55,3,10.55,10.55,10.55,"So, R. W. L.; Frieg, B.; Camino, J. D.; Silver, N. R. G.; Mao, A.; Stuart, E.; SchroÌder, G. F.; Watts, J. C.","Joel C. Watts","University of Toronto","2025-06-07","1","new results","cc_by","neuroscience","https://www.biorxiv.org/content/early/2025/06/07/2025.06.03.657690.source.xml","The existence of -synuclein conformational strains provides a potential explanation for the clinical and pathological differences among synucleinopathies such as Parkinsons disease and multiple system atrophy. However, how distinct -synuclein strains are formed in vivo remains unknown. Here, we examined whether unique strains of self-propagating -synuclein aggregates can arise within a consistent molecular environment. Unexpectedly, we observed conformational heterogeneity between individual preparations of -synuclein pre-formed fibrils (PFFs) generated by polymerizing recombinant wild-type or A53T-mutant human -synuclein under identical conditions. Moreover, we found that -synuclein aggregates formed spontaneously in the brains of a transgenic synucleinopathy mouse model were conformationally diverse, leading to the identification of three distinct disease subtypes. Propagation of putative PFF- and brain-derived -synuclein strains in mice initiated several distinct synucleinopathies, characterized by differences in disease onset times, cerebral -synuclein deposition patterns, and the conformational attributes of -synuclein aggregates. The conformational diversity of -synuclein aggregates across PFF preparations and between the brains of individual transgenic mice demonstrates that -synuclein can spontaneously form multiple self-propagating strains within an identical environment both in vitro and in vivo. This suggests that stochastic misfolding into distinct aggregate structures drives the emergence of -synuclein strains and implies that the intrinsic variability of common synucleinopathy research tools must be considered when designing and interpreting experiments.","NA","biorxiv",1749593357929
"Persistent ECM Scarring Reprograms Intestinal Stem Cells to Drive Chronic Inflammation","10.1101/2025.06.08.658481","biorxiv",8.35,4.1,8.35,8.35,8.35,"Adir, I.; Sochen, C.; Menachem, A. H.; Lebon, S.; Toval, B.; Holiar, V.; Davidzohn, N.; Salame, T. M.; Rosenhek-Goldian, I.; Savickas, S.; Sabino, F.; auf dem Keller, U.; Biton, M.; Sagi, I.","Irit Sagi","The Weizmann Institute of Science","2025-06-09","1","new results","cc_no","immunology","https://www.biorxiv.org/content/early/2025/06/09/2025.06.08.658481.source.xml","Tissue regeneration is conventionally viewed as a return to homeostasis. Here, we uncover that the extracellular matrix (ECM) in the colon undergoes a lasting pathological reprogramming following inflammation, forming a remodeled niche - modECM - that persistently disrupts intestinal stem cell (ISC) identity. Using temporal multi-omics, biomechanical profiling, and spatial fate mapping in murine colitis models, we show that modECM, characterized by Collagen XVIII accumulation and immune-driven proteolysis, redirects ISCs toward a wound-associated, squamous-like epithelial state with pro-inflammatory transcriptional signatures. Ex vivo, modECM alone reprograms ISC fate by suppressing Wnt signaling and activating immune recruitment pathways. In vivo, modECM-rich zones sustain T cell infiltration and KRT14 epithelial cell emergence from Lgr5 progenitors. This aberrant epithelial program is mirrored in inflamed rectal biopsies from ulcerative colitis patients. Our findings redefine the ECM as a long-lived instructive compartment that encodes injury memory and promotes maladaptive regeneration, positioning it as a potential therapeutic target in chronic inflammatory disease.","NA","biorxiv",1749593357929
"Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice","10.1101/2025.06.04.657879","biorxiv",8.149999999999999,1.35,8.149999999999999,8.149999999999999,8.149999999999999,"Rajan, A.; Varghese, A.; Hashardeen, S. P.; Babu, A. T.; Vijayan, V.; Thakur, P.","Poonam Thakur","School of Biology, IISER-Thiruvananthapuram","2025-06-08","1","new results","cc_no","neuroscience","https://www.biorxiv.org/content/early/2025/06/08/2025.06.04.657879.source.xml","Alpha-synuclein (-Syn) misfolding and aggregation are key drivers of Parkinsons disease (PD) pathology. Mutations and certain post-translational modifications impact its aggregation propensity and pathogenicity. Glycation, a non-enzymatic modification enhanced during hyperglycemia and aging, both known risk factors for PD, has been implicated in -Syn pathology. Although preformed -Syn-fibrils induce PD-like phenotypes in mice, the impact of glycation on their pathogenicity is unclear. In the current study, we glycated -Syn using methylglyoxal (MGO), a potent glycating agent, resulting in altered biophysical characteristics in comparison to non-glycated -Syn. Glycation inhibited the formation of typical beta sheet structures under aggregating conditions. Despite that, glycated -Syn assemblies induced dopaminergic neurodegeneration and neuroinflammation to a similar extent as the non-glycated -Syn fibrils upon their injection in the mouse substantia nigra (SN). However, these glycated assemblies triggered higher neuroinflammation and increased accumulation of receptors for advanced glycation end products (RAGE) compared to non-glycated fibrils. Consequently, an earlier onset of neuromuscular deficits and anxiety was observed in these mice. Thus, glycation of -Syn causes distinct PD-associated pathology compared to non-glycated -Syn, causing an earlier onset of motor symptoms. These findings provide insight into how glycation of -Syn due to hyperglycemia may contribute to an increased risk of PD in diabetic populations.","NA","biorxiv",1749593357929
"AlphaFold models of host-pathogen interactions elucidate the prevalence and structural modes of molecular mimicry","10.1101/2025.06.04.657796","biorxiv",10.95,2.2,8.1,10.95,10.95,"Baptista, D.; Gomez-Lucas, L.; JaÌnes, J.; Krogan, N. J.; Joao Amorim, M.; Ivarsson, Y.; Beltrao, P.","Pedro Beltrao","ETH Zurich","2025-06-06","1","new results","cc_by","bioinformatics","https://www.biorxiv.org/content/early/2025/06/06/2025.06.04.657796.source.xml","Pathogens exploit host cellular machinery through protein-protein interactions (PPIs), often using molecular mimicry to hijack host cellular processes. While there have been thousands of host-pathogen PPIs determined to date, the lack of structural information for these impedes the study of the prevalence of molecular mimicry and convergent evolution of protein interaction interfaces. To address this, we benchmarked AlphaFold2 and 3 for prediction of structures of host-pathogen interactions observing that accurate models can be retrieved when ranking by modelling confidence, despite an overall low performance. We predicted structures for 6,782 pathogen-human PPIs yielding 803 models of higher confidence. Most pathogen proteins interacting with a common human protein are predicted to do so via the same interface, suggesting a high degree of convergent evolution of protein interaction interfaces. When comparing structural models from host-pathogen and host-host interactions, we observe that a majority of pathogen proteins are predicted to target existing human PPI interfaces. We categorized instances of mimicry into different modes, occurring at different frequencies: 1) via the same domain family (least common); 2) via a similar structural motif; and 3) via a similar linear motif (most common). We selected examples of linear motif interactions for binding assay testing, confirming 8 out of 12 predicted interfaces, including 3 viral linear motif interactions. This validates AlphaFolds ability to model some host-pathogen interactions and the mechanisms underlying molecular mimicry. This work showcases the value of large-scale structural modelling to study convergent evolution of host-pathogen interactions and how molecular mimicry may contribute to infection or host defense.","NA","biorxiv",1749593357929
"Age-specific trends in colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: a population-based time-series analysis","10.1101/2025.04.21.25326138","medrxiv",84.86,1,8.08,53.66,84.36,"Meyers, A. L.; Dowty, J. G.; Mahmood, K.; Macrae, F. A.; Rosty, C.; Buchanan, D. D.; Jenkins, M. A.","Aaron L Meyers","Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.","2025-04-24","1","PUBLISHAHEADOFPRINT","cc_by_nd","epidemiology","https://www.medrxiv.org/content/early/2025/04/24/2025.04.21.25326138.source.xml","BackgroundEarly-onset bowel cancer incidence (age <50 years) has increased worldwide and is highest in Australia, but how this varies across histology and anatomical site remains unclear. We aimed to investigate appendiceal, proximal colon, distal colon, rectal, and anal cancer incidence trends by age and histology in Australia.

MethodsCancer incidence rate data were obtained from all Australian cancer registries (1990-2020 period). Birth cohort-specific incidence rate ratios (IRRs) and annual percentage change in rates were estimated using age-period-cohort modelling and joinpoint regression.

FindingsAfter excluding neuroendocrine neoplasms, early-onset cancer incidence rose 5-9% annually, yielding 5,341 excess cases (2 per 100,000 person-years; 12% appendix, 45% colon, 36% rectum, 7% anus; 20-214% relative increase). Trends varied by site, period, and age: appendiceal cancer rose from 1990-2020 in 30-49-year-olds; colorectal cancers rose from around 1990-2010 in 20-29-year-olds and from 2010-2020 in 30-39-year-olds; anal cancer rose from 1990-2009 in 40-49-year-olds. Across all sites, IRRs increased with successive birth cohorts since 1960. Notably, adenocarcinoma incidence in the 1990s versus 1950s birth cohort was 2-3-fold for colorectum and 7-fold for appendix. The greatest subtype-specific increases occurred for appendiceal mucinous adenocarcinoma, colorectal non-mucinous adenocarcinoma, and anal squamous cell carcinoma. Only later-onset (age [&ge;]50) colorectal and anal adenocarcinoma rates declined. Appendiceal tumours, neuroendocrine neoplasms (all sites), anorectal squamous cell carcinomas, and colon signet ring cell carcinomas rose across early-onset and later-onset strata.

InterpretationAppendiceal, colorectal, and anal cancer incidence is rising in Australia with variation across age and histology, underscoring the need to identify factors driving these trends.

FundingALM is supported by an Australian Government Research Training Program Scholarship, Rowden White Scholarship, and WP Greene Scholarship. DDB is supported by a National Health and Medical Research Council of Australia (NHMRC) Investigator grant (GNT1194896), a University of Melbourne Dame Kate Campbell Fellowship, and by funding awarded to The Colon Cancer Family Registry (CCFR, www.coloncfr.org) from the National Cancer Institute (NCI), National Institutes of Health (NIH) [award U01 CA167551]. MAJ is supported by an NHMRC Investigator grant (GNT1195099), a University of Melbourne Dame Kate Campbell Fellowship, and by funding awarded to the CCFR from NCI, NIH [award U01 CA167551].","NA","medrxiv",1749593357929
"Bacterial peptide deformylase inhibitors induce prophages in competitors","10.1101/2025.06.06.656871","biorxiv",7.35,0.25,7.35,7.35,7.35,"Chen, J.; Pfeifer, K.; Steensen, K.; Crooke, A. M.; Wolfram, M.; Bobonis, J.; Lopatina, A.; Bartlau, N.; Hussain, F. A.; Balskus, E. P.; Polz, M. F.; Blainey, P. C.","Paul C Blainey","Massachusetts Institute of Technology","2025-06-06","1","new results","cc_by_nc_nd","microbiology","https://www.biorxiv.org/content/early/2025/06/06/2025.06.06.656871.source.xml","While antibiotics mediate chemical warfare among microbes, their roles in the wild extend beyond direct growth inhibition(1). Some antibiotics have the potential to mediate interference competition by triggering a bacterial stress response that subsequently activates endogenous viruses integrated in bacterial genomes (prophages). Canonically, this activation is regulated by the SOS response upon DNA damage. Here we show that a metabolite produced by natural isolates of Vibrio ordalii circumvents the SOS response by directly triggering prophage induction in other Vibrio species, co-occurring in the same environment. While the metabolite was previously classified as a broad-spectrum antibiotic, we observe how it acts as a peptide deformylase inhibitor that specifically induces certain prophages, even when target bacterial cells carry multiple other prophages. Its biosynthetic gene cluster, or ord cluster, also encodes its own peptide deformylase (OrdE) which provides self-immunity to producer strains. Likewise, among natural Vibrio isolates that carry similar prophages, resistance against the ord metabolite was found in those that had acquired a divergent second peptide deformylase. Finally, we show that prophage induction by the ord cluster prevents slower-growing producer strains from being outcompeted by their otherwise fast-growing competitors if they carry an inducible prophage. Thus, we demonstrate how natural products play additional impactful roles in communities beyond antibiotic activity and that prophage induction serves as an interference competition strategy, sustaining community diversity.","NA","biorxiv",1749593357930
"Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infection","10.1101/2025.04.16.25325949","medrxiv",514.0000000000005,0.5,7.35,7.35,21.15,"Lucena Lage, S.; Bricker-Holt, K.; Rocco, J. M.; Rupert, A.; Donovan, F. X.; Abramzon, Y. A.; Chandrasekharappa, S. C.; McNinch, C.; Cook, L.; Pinheiro Amaral, E.; Rosenfeld, G.; Dalhuisen, T.; Eun, A.; Hoh, R.; Fehrman, E.; Martin, J. N.; Deeks, S. G.; Henrich, T. J.; Peluso, M. J.; Sereti, I.","Irini Sereti","Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)","2025-04-17","1","PUBLISHAHEADOFPRINT","cc0","infectious diseases","https://www.medrxiv.org/content/early/2025/04/17/2025.04.16.25325949.source.xml","SARS-CoV-2 can cause a variety of post-acute sequelae including Long COVID19 (LC), a complex, multisystem disease characterized by a broad range of symptoms including fatigue, cognitive impairment, and post-exertional malaise. The pathogenesis of LC is incompletely understood. In this study, we performed comprehensive cellular and transcriptional immunometabolic profiling within a cohort that included SARS-CoV-2-naive controls (NC, N=30) and individuals with prior COVID-19 ([~]4-months) who fully recovered (RC, N=38) or went on to experience Long COVID symptoms (N=58). Compared to the naive controls, those with prior COVID-19 demonstrated profound metabolic and immune alterations at the proteomic, cellular, and epigenetic level. Specifically, there was an enrichment in immature monocytes with sustained inflammasome activation and oxidative stress, elevated arachidonic acid levels, decreased tryptophan, and variation in the frequency and phenotype of peripheral T-cells. Those with LC had increased CD8 T-cell senescence and a distinct transcriptional profile within CD4 and CD8 T-cells and monocytes by single cell RNA sequencing. Our findings support a profound and persistent immunometabolic dysfunction that follows SARS-CoV-2 which may form the pathophysiologic substrate for LC. Our findings suggest that trials of therapeutics that help restore immune and metabolic homeostasis may be warranted to prevent, reduce, or resolve LC symptoms.","NA","medrxiv",1749593357930
"RetiGene, a comprehensive gene atlas for inherited retinal diseases (IRDs)","10.1101/2025.06.08.653722","biorxiv",7.1499999999999995,3.45,7.1499999999999995,7.1499999999999995,7.1499999999999995,"Quinodoz, M.; Celik, E.; Kamdar, D.; Cancellieri, F.; Kaminska, K.; Ullah, M.; Barberan-Martinez, P.; Bouckaert, M.; Corton, M.; Delanote, E.; Fernandez-Caballero, L.; Garcia, G. G.; Holtes, L. K.; Karali, M.; Lopez, I.; Peter, V. G.; Schneider, N.; Vincke, L.; Ayuso, C.; Banfi, S.; Bocquet, B.; Coppieters, F.; Cremers, F.; Inglehearn, C.; Iwata, T.; Kalatzis, V.; Koenekoop, R. K.; Millan, J. M.; Sharon, D.; Toomes, C.; Rivolta, C.","Carlo Rivolta","IOB / University of Basel","2025-06-08","1","new results","cc_by","genetics","https://www.biorxiv.org/content/early/2025/06/08/2025.06.08.653722.source.xml","Inherited retinal diseases (IRDs) are rare disorders, typically presenting as Mendelian traits, that result in stationary or progressive visual impairment. They are characterized by extensive genetic heterogeneity, possibly the highest among all human genetic diseases, as well as diverse inheritance patterns. Despite advances in gene discovery, limited understanding of gene function and challenges in accurately interpreting variants continue to hinder both molecular diagnosis and genetic research in IRDs. One key problem is the absence of a comprehensive and widely accepted catalogue of disease genes, which would ensure consistent genetic testing and reliable molecular diagnoses. With the rapid pace of IRD gene discovery, gene catalogues require frequent validation and updates to remain clinically and scientifically useful. To address these gaps, we developed RetiGene, an expert-curated gene atlas that integrates variant data, bulk and single-cell RNA sequencing, and functional annotations. Through the integration of diverse data sources, RetiGene supports candidate gene prioritization, functional studies, and therapeutic development in IRDs.","NA","biorxiv",1749593357930
"Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season","10.1101/2025.01.30.25321421","medrxiv",2300.299999999952,1,3.85,12.799999999999999,186.54999999999967,"Shrestha, N. K.; Burke, P. C.; Nowacki, A. S.; Gordon, S. M.","Nabin K. Shrestha","Cleveland Clinic","2025-04-04","3","PUBLISHAHEADOFPRINT","cc_by_nc_nd","infectious diseases","https://www.medrxiv.org/content/early/2025/04/04/2025.01.30.25321421.source.xml","BackgroundThe purpose of this study was to evaluate the effectiveness of the influenza vaccine during the 2024-2025 respiratory viral season.

MethodsEmployees of Cleveland Clinic in employment in Ohio on October 1, 2024, were included. The cumulative incidence of influenza among those in the vaccinated and unvaccinated states was compared over the following 25 weeks. Protection provided by vaccination (analyzed as a time-dependent covariate) was evaluated using Cox proportional hazards regression.

ResultsAmong 53402 employees, 43857 (82.1%) had received the influenza vaccine by the end of the study. Influenza occurred in 1079 (2.02%) during the study. The cumulative incidence of influenza was similar for the vaccinated and unvaccinated states early, but over the course of the study the cumulative incidence of influenza increased more rapidly among the vaccinated than the unvaccinated. In an analysis adjusted for age, sex, clinical nursing job, and employment location, the risk of influenza was significantly higher for the vaccinated compared to the unvaccinated state (HR, 1.27; 95% C.I., 1.07 - 1.51; P = 0.007), yielding a calculated vaccine effectiveness of -26.9% (95% C.I., -55.0 to -6.6%).

ConclusionsThis study found that influenza vaccination of working-aged adults was associated with a higher risk of influenza during the 2024-2025 respiratory viral season, suggesting that the vaccine has not been effective in preventing influenza this season.

SummaryAmong 53402 working-aged Cleveland Clinic employees, we were unable to find that the influenza vaccine has been effective in preventing infection during the 2024-2025 respiratory viral season.","NA","medrxiv",1749593357930
"Towards Causal Interpretability in Deep Learning for Parkinson's Detection from Voice Data","10.1101/2025.04.25.25326311","medrxiv",73.42999999999999,0,0,0,72.17999999999999,"Ananthanarayanan, A.; Senivarapu, S.; Murari, A.","Aniruth Ananthanarayanan","University of North Texas","2025-05-06","3","PUBLISHAHEADOFPRINT","cc_by_nc_nd","health informatics","https://www.medrxiv.org/content/early/2025/05/06/2025.04.25.25326311.source.xml","This research introduces a comprehensive framework for Parkinsons Disease (PD) detection using voice recording data. We implemented and evaluated multiple deep learning models, including a baseline Convolutional Neural Network (CNN), an uncertainty-aware Monte Carlo-Dropout CNN (MCD-CNN), as well as a few-shot learning approach to address dataset size limitations. Our models achieved an accuracy over 90% in classifying PD patients using vocal biomarkers, with the ensemble model demonstrating the highest performance. We employed data augmentation techniques to address class imbalance and enhance generalization. Causal feature analysis revealed that the Noise-to-Harmonics Ratio (NHR), Recurrence Period Density Entropy (RPDE), and MDVP jitter parameters were among the most significant vocal biomarkers for PD detection, in order of estimated effect magnitude. Across deep learning models, features exhibiting the strongest absolute correlation with outputs consistently showed the largest estimated effect magnitudes. The few-shot learning approach showed promising results as well, even with limited training examples. This work demonstrates the use of causal feature analysis to validate the analysis of deep learning models, potentially enabling accessible and interpretable non-invasive screening tools.","NA","medrxiv",1749593357930
"Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions","10.1101/2025.03.13.25323700","medrxiv",44.75,0,0,0,42,"Telis, N.; Stoller, D.; Chapman, C. N.; Chahal, C. A. A.; Judge, D.; Olson, D. A.; Grzymski, J. J.; Kruisselbrink, T.; Washington, N. L.; Cirulli, E. T.","Natalie Telis","Helix","2025-03-13","1","PUBLISHAHEADOFPRINT","cc_by_nc","pharmacology and therapeutics","https://www.medrxiv.org/content/early/2025/03/13/2025.03.13.25323700.source.xml","ObjectiveIn spite of evidence and recommendations reflecting the importance of pharmacogenomic testing, most prescriptions are still given without testing. We demonstrate the real world implications of the use of testing and evaluate adverse events and outcomes in individuals who did not receive pharmacogenomic testing for clopidogrel.

MethodsWe analyzed ~100K individuals with paired EHR and exome sequencing data from population health studies administered at multiple medical centers using the Helix Exome+(R) assay. We inferred clopidogrel dosage by processing the prescription with an LLM. We identified all instances of individuals with at least one prescription that is not in concordance with their CYP2C19 genotype. Lastly, we identify instances of thrombosis using a comprehensive codeset based on ICD9, ICD10, and SNOMED terms.

ResultsWe identified 16,140 prescriptions of clopidogrel given to 3,853 participants. We found that 29% of these individuals have a mismatch between the recommended clopidogrel dosage guideline based on their CYP2C19 genotype and their actual prescribed daily dosage. 25% of poor metabolizers experienced thrombosis, with 40% occurring within 2 months of treatment. Poor and intermediate metabolizers receiving clopidogrel are much more likely to experience thrombosis and myocardial infarction (binomial p-value = 0.001).

ConclusionsWe estimate a 38% excess of adverse events occur in poor and intermediate metabolizers relative to normal and rapid metabolizers. The lack of testing may be responsible for 1 thrombosis event per every ~30 people prescribed clopidogrel.","NA","medrxiv",1749593357930
"Physical Fitness and Body Composition in Transgender vs. Cisgender Individuals: A Systematic Review and Meta-Analysis","10.1101/2025.05.05.25326994","medrxiv",36.49999999999999,0,1,2.35,36.24999999999999,"Mendes Sieczkowska, S.; Caruso Mazzolani, B.; Reis Coimbra, D.; Longobardi, I.; Rossilho Casale, A.; Fajardo Villela Martins Pompilio da Hora, J. D.; Roschel, H.; Gualano, B.","Bruno Gualano","University of Sao Paulo","2025-05-06","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","sports medicine","https://www.medrxiv.org/content/early/2025/05/06/2025.05.05.25326994.source.xml","ObjectiveTo compare fitness and body composition between transgender and cisgender individuals.

DesignSystematic review and meta-analysis.

Data sourcesPubMed, Web of Science, Embase, and SportDiscus databases were searched in June 2024, supplemented by manual citation reviews.

Eligibility criteriaInclusion criteria comprised studies of transgender individuals comparing physical fitness/body composition pre-to-post gender-affirming hormone therapy (GAHT) or vs. cisgender controls, with quantitative outcomes reported.

ResultsFifty-one studies (6,434 participants) were analyzed. Transgender women (TW) exhibited comparable fat mass to cisgender women (CW), but higher than cisgender men (CM). TW showed greater lean mass than CW, but lower than CM. Upper- and lower-body strength were similar between TW and CW, but lower than CM. TW and CW had similar VO2 peak, but TW exhibited lower values than CM. Transgender men (TM) exhibited similar fat mass to CW, but higher than CM. TM showed higher lean mass than CW, but lower than CM. Upper-body strength was higher in TM than CW, but lower than CM. GAHT in TW increased fat mass, reduced lean mass and upper-body strength, with no differences in lower-body strength over 1-3 years. TM demonstrated reduced fat mass and increased lean mass, upper- and lower-body strength post-GAHT. Risk of bias was moderate for most studies, with limited observations for specific outcomes (e.g., VO2 peak).

ConclusionWhile TW exhibited higher lean mass than CW, their physical fitness was comparable. Current evidence is limited but does not justify blanket bans based on assumptions of inherent athletic advantages for TW over CW.

WHAT IS ALREADY KNOWN ON THIS TOPICO_LIThe inclusion of transgender women in female sports categories remains a highly contentious subject.
C_LIO_LIExisting studies suggest that gender-affirming hormone therapy (GAHT) alters body composition in transgender individuals, but evidence on functional performance outcomes (e.g., strength, endurance) remains inconsistent.
C_LIO_LIPolicies advocating blanket bans on transgender women (TW) in female sports often cite residual advantages from prior testosterone exposure, despite limited empirical support for sustained performance disparities post-GAHT.
C_LI

WHAT THIS STUDY ADDS?O_LIThis systematic review and meta-analysis synthesizes data from 51 studies (6,434 participants), demonstrating that, while TW showed higher absolute lean mass than cisgender women (CW), there are no significant differences in upper/lower-body strength or VO{square}peak after 1-3 years of GAHT.
C_LIO_LIThese findings challenge the validity of blanket bans predicated on assumptions of inherent athletic superiority of TW over CW.
C_LIO_LITransgender men (TM) exhibit body composition and strength metrics intermediate between CW and cisgender men (CM) post-GAHT.
C_LIO_LICritical research gaps are identified, including a lack of long-term GAHT data, underrepresentation of transgender athletes, and inconsistent controls for confounders (e.g., training history, puberty blocking). Future studies must prioritize sport-specific performance metrics and longitudinal designs to inform equitable policies.
C_LI","NA","medrxiv",1749593357930